Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s ...

The global AI In Life science Analytics Market is projected to be valued at USD 1.9 billion in 2024 and reach USD 3.6 billion ...

ADC Therapeutics SA (NYSE: ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings ...

Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...

Q1 2025 Earnings Call Transcript May 13, 2025 Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

Welcome to the Acumen Pharmaceuticals Q1 2025 conference call and webcast. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded.

The best ways to encourage independent reading in kids with dyslexia involve using structured support, tailored resources, and positive motivation.

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising ...

EVG is participating with the following professional development course, papers and posters in the ECTC technical program ...